ADRB1 rs1081253: Understanding Your Beta-1 Adrenergic Receptor
The rs1081253 variant is a genetic change located within the ADRB1 gene, which encodes the beta-1 adrenergic receptor. This receptor is a key component of the sympathetic nervous system, and variations here are studied for their potential influence on heart rate regulation and cardiovascular responses to exercise.
What each genotype means
Glycine-associated receptor profile
This genotype corresponds to the Gly389 variant of the ADRB1 gene. Research suggests this version of the receptor may exhibit lower signaling activity compared to the Arg389 variant, potentially influencing cardiovascular responses to exercise and catecholamine stimulation. If you are taking beta-blocker medications, please discuss your treatment and dosing with your clinician or pharmacist, as this variant may influence drug response.
This genotype is common globally, though frequencies vary significantly by ancestry.
Mixed receptor activity profile
You carry one copy of the Gly389 allele and one copy of the Arg389 allele. This combination results in a mixed receptor signaling profile, which may influence how your heart and metabolism respond to exercise or stress. Because this variant can affect how your body processes certain cardiovascular medications, please consult your healthcare provider regarding any prescribed beta-blocker therapy.
This heterozygous genotype is frequently observed across diverse human populations.
Arginine-associated receptor profile
This genotype corresponds to the Arg389 variant, which is often associated with higher receptor signaling activity in response to catecholamines. Some studies have linked this variant to differences in exercise performance and cardiovascular adaptation, as well as potential variations in response to beta-blocker medications. Please discuss your cardiovascular health and any medication management with your doctor or pharmacist.
This genotype is common and found in most populations, with prevalence rates varying by ethnic background.
What is rs1081253 and Where is it Located?
The rs1081253 variant is a single nucleotide polymorphism (SNP) found within the ADRB1 gene. In genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. The ADRB1 gene is located on human chromosome 10 at position 10q25.3. This specific variant is part of a broader set of genetic markers within the gene that researchers monitor to understand how subtle differences in our DNA code might contribute to physiological diversity. Because it sits within a gene responsible for critical signaling pathways, scientists investigate whether this specific location influences how the body processes signals from catecholamines like epinephrine and norepinephrine.
The Role of the ADRB1 Gene
The ADRB1 gene provides instructions for creating the beta-1 adrenergic receptor, a protein primarily found in the heart. These receptors act as sensors for the sympathetic nervous system, responding to hormones like adrenaline. When these hormones bind to the receptor, they trigger a cascade of cellular events that increase heart rate, improve the force of heart muscle contractions, and regulate cardiac output. Because the heart relies heavily on these receptors to adjust its performance during physical activity or stress, the ADRB1 gene is a primary focus for researchers studying cardiovascular physiology. Proper function of this receptor is essential for maintaining homeostatic control of the heart, and variations in the gene may alter the sensitivity or density of these receptors in cardiac tissue.
Research Associations and Evidence Strength
Research into ADRB1 variants often focuses on how they correlate with resting heart rate and cardiovascular adaptation to exercise. While some studies suggest that variations in the ADRB1 gene may influence how individuals respond to beta-blocker medications or exercise training, the evidence for specific SNPs like rs1081253 remains moderate. It is important to note that cardiovascular traits are complex and influenced by many genes, environmental factors, and lifestyle choices. Current literature indicates that while there are statistical associations between ADRB1 variants and heart-related metrics, these findings are not always consistent across different populations. Consequently, this variant should be viewed as one small piece of a much larger, complex biological puzzle rather than a definitive predictor of athletic performance or health outcomes.
Population Frequency
The rs1081253 variant is considered a common SNP, meaning it is found at a significant frequency across various global populations. Genetic databases indicate that the different alleles for this variant are widely distributed, though the exact proportions can vary depending on ancestral background. Because it is common, it is frequently included in large-scale genomic studies aimed at understanding the genetic architecture of cardiovascular traits. Researchers use this frequency data to ensure that studies are representative and to better understand how genetic diversity contributes to the range of normal human physiological responses.
What You Can and Cannot Do With This Information
Understanding your genotype for rs1081253 can provide insight into the genetic factors that may influence your cardiovascular system, but it is not a diagnostic tool. You cannot use this information to predict your athletic potential, diagnose a heart condition, or determine your risk for cardiovascular disease. Genetic associations are statistical in nature and do not account for the significant impact of diet, exercise, and medical history. If you are interested in how your genetics might influence your response to medications, such as beta-blockers, or if you have concerns about your heart health, you must discuss these topics with a qualified clinician or pharmacist. They can provide personalized guidance based on your full medical profile rather than a single genetic marker.
How common is this variant?
The rs1081253 variant is a common polymorphism found across diverse human populations, with its specific allele frequencies varying by ancestry.
Frequently asked questions
Can rs1081253 predict my athletic performance?
No. While ADRB1 is involved in cardiovascular regulation, athletic performance is a complex trait influenced by thousands of genes, training, nutrition, and environment. A single SNP cannot determine your fitness potential.
Does this variant mean I have a heart condition?
No. This variant is a common genetic difference found in healthy individuals. It is not a diagnostic marker for heart disease or any other medical condition.
Should I change my medication based on this SNP?
Absolutely not. Never change your medication or dosage based on genetic information without consulting your doctor or pharmacist. They are the only ones qualified to manage your treatment plan.
Where can I learn more about my specific genotype?
You can consult with a genetic counselor or your primary care physician. They can help you interpret genetic information in the context of your overall health and medical history.
Sources & further reading
Educational information only, last refreshed 10/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1081253?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADRB1
The Ser49Gly missense polymorphism alters beta-1 adrenergic receptor downregulation, impacting resting heart rate and peak cardiovascular output during endurance performance.
Rare missense variant (Ala187Val) in the beta-1 adrenergic receptor gene ADRB1 that causes familial natural short sleep phenotype via altered adrenergic signaling in sleep-wake circuitry.
A rare missense variant (p.Ala187Val) in the beta-1 adrenergic receptor gene ADRB1 linked to hereditary natural short sleep trait in humans.